SWOG clinical trial number
SWOG-8728
Evaluation of Didemnin B in Metastatic Adenocarcinoma of the Kidney
Closed
Phase
Published
Abbreviated Title
Evaluation of Didemnin B in Metastatic Adenocarcinoma of the Kidney
Activated
01/01/1988
Closed
02/01/1989
Publication Information Expand/Collapse
1992
Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney: A Southwest Oncology Group study.
Prognostic factors in patients with advanced renal cell carcinoma (RCC): The Southwest Oncology Group experience.
1989
Phase II trial of didemnin B (Did-B) in advanced adenocarcinomaof the kidney.